Try it
General Medicine · Cardiology: BNP and neprilysin inhibition
Sample itemA patient with heart failure is switched from enalapril to sacubitril-valsartan. Which biomarker interpretation is correct afterwards?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. BNP may rise because neprilysin degrades it, so NT-proBNP is preferred for monitoring
Neprilysin breaks down BNP, so inhibition raises BNP levels without worsening disease. NT-proBNP is not a neprilysin substrate and remains reliable for monitoring. Sacubitril-valsartan must not be combined with ACE inhibitors because of angioedema risk.
Option by option
A. BNP may rise because neprilysin degrades it, so NT-proBNP is preferred for monitoring (correct)
Correct. Use NT-proBNP when on an ARNI.
B. Troponin rises predictably
Troponin is unrelated to the drug.
C. Both BNP and NT-proBNP are unaffected
BNP is affected, so they are not both unaffected.
D. NT-proBNP rises because neprilysin degrades it
NT-proBNP is not degraded by neprilysin.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…